Just days after Twitter was considering a ‘poison pill’ that would keep Elon Musk from buying the company, its board is now seriously considering his $46.5 billion offer.
Obtaining commitments for the financing was a turning point for how the board viewed Musk’s bid of $54.20 a share.
The Atlantic’s staff writer Derek Thompson joins host Peter O’Dowd with the latest.
This article was originally published on WBUR.org.
Copyright 2022 NPR. To see more, visit https://www.npr.org.
